News Sentiment

CERT sentiment intelligence

Certara Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 6.77 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.9% over one week, +30.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -2.9% Price reacting lower
Trend fit Trend inactive 30.2% over four weeks
Fair value -44.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 34
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 8
TradingView 8
Market source 6
simplywall.st 4
Simply Wall Street 3
Investing.com 3
The Manila Times 2
scanx.trade 1

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 10
Deals and strategy 7
Regulatory and legal 4
Balance sheet 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 50
The Manila Times Direct company coverage

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

Certara, Inc. (Nasdaq: CERT) announced that it will release its second quarter 2026 financial results before market open on Tuesday, August 4th, 2026. Company management will host a conference call at 8:30 AM ET to discuss the results, and a live webcast will be available on the

Tone
Neutral 50/100
Event
Earnings
Published
16 Jul 2026 04:27
Source
The Manila Times
scanx.trade Direct company coverage

Certara to report Q2 2026 financial results on August 4

Certara, Inc. announced it will release its second-quarter 2026 financial results before market open on August 4, 2026, followed by a conference call at 8:30 AM ET. The company, a specialist in model-informed drug development, requires investors to register online in advance to p

Tone
Negative 20/100
Event
Earnings
Published
15 Jul 2026 22:10
Source
scanx.trade
Stock Titan Direct company coverage

Certara sets Aug. 4 call to discuss second-quarter results

Certara (Nasdaq: CERT) announced it will release its second-quarter 2026 financial results before market open on Tuesday, August 4, 2026. Company management will host a conference call to discuss the results at 8:30 AM ET, and investors are required to register online in advance.

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 20:10
Source
Stock Titan
GuruFocus Direct company coverage

BlackRock, Inc.'s Strategic Acquisition of Certara Inc. Shares

BlackRock, Inc. has increased its stake in Certara Inc. by acquiring an additional 3,724,184 shares, bringing their total holdings to 18,032,062 shares. This strategic move, despite Certara's current financial challenges and negative year-to-date performance, suggests BlackRock's

Tone
Positive 65/100
Event
Deals and strategy
Published
15 Jul 2026 01:03
Source
GuruFocus
Stock Titan Direct company coverage

Dimensional Fund Advisors details Certara Inc (CERT) 3.9% ownership position

Dimensional Fund Advisors LP has filed an amended Schedule 13G, disclosing a beneficial ownership of 6,022,686 shares of Certara Inc (CERT) common stock, which represents 3.9% of the class as of June 30, 2026. Dimensional holds sole voting power over 5,913,513 shares and sole dis

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 17:03
Source
Stock Titan
Simply Wall Street Direct company coverage

Certara (CERT) Taps NVIDIA For AI Drug Development, Is It A Bargain?

Certara (CERT) announced a partnership with NVIDIA to integrate the BioNeMo Agent Toolkit into its open AI platform for drug development, driving recent investor interest and a 30-day share price increase of over 30%. While some valuation models suggest Certara is undervalued due

Tone
Positive 63/100
Event
Deals and strategy
Published
14 Jul 2026 10:42
Source
Simply Wall Street
Sahm Direct company coverage

What Certara (CERT)'s NVIDIA BioNeMo Partnership Means For Shareholders

Certara announced a partnership with NVIDIA to integrate the BioNeMo Agent Toolkit into its AI-driven biosimulation platform. This collaboration aims to enhance drug development tasks and reshape computational biology workflows, aligning with Certara's strategy to make AI-enabled

Tone
Neutral 50/100
Event
Deals and strategy
Published
10 Jul 2026 01:10
Source
Sahm
Pluang Direct company coverage

Certara faces securities fraud probe after Q1 r...

Certara, Inc. is under investigation by Pomerantz LLP for potential securities fraud. This probe follows a Q1 2026 report revealing a 4% decline in services revenue, a 14% drop in bookings, and the company's decision to exit its regulatory business segment due to inconsistent per

Tone
Negative 19/100
Event
Regulatory and legal
Published
09 Jul 2026 21:45
Source
Pluang
PR Newswire Direct company coverage

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

Pomerantz LLP is investigating potential claims on behalf of investors of Certara, Inc. (NASDAQ: CERT) regarding possible securities fraud or unlawful business practices. This investigation follows Certara's reported decline in services revenue and bookings in Q1 2026, its exit f

Tone
Negative 18/100
Event
Regulatory and legal
Published
09 Jul 2026 17:39
Source
PR Newswire
Stock Titan Direct company coverage

BlackRock (CERT) discloses 18.0M shares; 11.6% ownership reported

BlackRock, Inc. has filed an amended Schedule 13G disclosing beneficial ownership of 18,032,062 shares of Certara, Inc. common stock, which represents an 11.6% stake in the company. The filing specifies that BlackRock holds sole voting power over 17,841,248 shares and sole dispos

Tone
Neutral 50/100
Event
Deals and strategy
Published
09 Jul 2026 01:10
Source
Stock Titan
Simply Wall Street Direct company coverage

AI Chips Today - Certara-NVIDIA Partnership Revolutionizes AI in Drug Development

Certara has partnered with NVIDIA to integrate the NVIDIA BioNeMo Agent Toolkit into its AI platform for drug discovery and development. This collaboration aims to accelerate drug development by using AI-driven agents and biosimulation models to computationally simulate human bio

Tone
Neutral 50/100
Event
Deals and strategy
Published
08 Jul 2026 11:10
Source
Simply Wall Street
Investing.com Direct company coverage

Certara partners with Nvidia to integrate AI agents into drug development platform

Certara, Inc. announced a partnership with Nvidia to integrate AI-driven agent technology, specifically Nvidia’s BioNeMo Agent Toolkit, into its drug development platform. This collaboration aims to enhance drug development processes by generating insights across various stages,

Tone
Positive 72/100
Event
Deals and strategy
Published
08 Jul 2026 01:10
Source
Investing.com
Benzinga Direct company coverage

Nvidia Powers AI Agent Strategies for Certara, Silo Pharma - NVIDIA (NASDAQ:NVDA)

Nvidia is expanding its influence in the life sciences AI sector through collaborations with Certara Inc. and Silo Pharma Inc. Certara is integrating Nvidia's BioNeMo Agent Toolkit into its AI-driven drug development platform to enhance drug discovery workflows, while Silo Pharma

Tone
Positive 67/100
Event
Market update
Published
07 Jul 2026 18:41
Source
Benzinga
The Manila Times Direct company coverage

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

Certara is partnering with NVIDIA to enhance its integrated AI platform for drug discovery and development using the NVIDIA BioNeMo Agent Toolkit. This collaboration aims to unify Certara's biosimulation software, proprietary datasets, and scientific expertise with AI-driven agen

Tone
Positive 73/100
Event
Market update
Published
07 Jul 2026 12:05
Source
The Manila Times
Stock Titan Direct company coverage

Certara teams with NVIDIA to speed drug discovery with AI agents

Certara announced a partnership with NVIDIA to integrate the NVIDIA BioNeMo Agent Toolkit into its open integrated AI platform. This collaboration aims to accelerate drug discovery and development by enabling AI agents to autonomously generate specialized insights across the life

Tone
Positive 66/100
Event
Deals and strategy
Published
07 Jul 2026 12:00
Source
Stock Titan
TradingView Direct company coverage

Price to earnings forward of Certara, Inc. – HAM:700

This article provides the "Price to earnings forward" value for Certara, Inc. (HAM:700) on the Hamburg Stock Exchange. It includes details about the period, value, and change, noting that the data is provided by FactSet Research Systems Inc.

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 16:39
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Certara, Inc. – HAM:700

This article provides financial information for Certara, Inc. (HAM:700), specifically focusing on its Price to Sales forward metric. The content highlights the company's stock exchange listing on the Hamburg Stock Exchange and indicates that no recent trades have occurred.

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 12:13
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Certara, Inc. – NASDAQ:CERT

This article provides financial information for Certara, Inc. (NASDAQ: CERT), focusing on its enterprise value to revenue forward. The content appears to be a stub or a section of a larger financial data report, likely from TradingView, given the source and formatting. It details

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 02:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Certara, Inc. – HAM:700

This article provides a brief mention of Certara, Inc.'s enterprise value to revenue forward, listed on the Hamburg Stock Exchange under the ticker HAM:700. It appears to be a stub or a section within a larger financial data platform, indicating the company's financial overview i

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 01:40
Source
TradingView
Simply Wall Street Direct company coverage

Does Certara (CERT) Joining the Russell 2000 Recast Its Biosimulation Investment Narrative?

Certara, Inc. (CERT) has been reclassified into the Russell 2000 index, indicating a shift towards smaller-cap status, while also launching its Bio Venture Catalyst for early-stage biotechs and announcing a CFO transition. This article examines how the index change, coupled with

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 18:10
Source
Simply Wall Street
富途牛牛 Direct company coverage

Should You Investigate Certara, Inc. (NASDAQ:CERT) At US$6.36?

This article evaluates whether Certara, Inc. (NASDAQ:CERT) is a worthwhile investment at its current price of US$6.36. It likely delves into the company's financials, market position, and future prospects to help potential investors make an informed decision.

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 23:39
Source
富途牛牛
www.marketscreener.com Direct company coverage

Certara, Inc.(NasdaqGS: CERT) added to Russell 2000 Index

Certara, Inc. (NasdaqGS: CERT), a provider of biosimulation software and services, has been added to the Russell 2000 Index. This inclusion means the company's stock will now be part of this widely recognized small-cap index, potentially increasing its visibility and liquidity. T

Tone
Positive 67/100
Event
Balance sheet
Published
29 Jun 2026 18:40
Source
www.marketscreener.com
TradingView Direct company coverage

Enterprise value to EBITDA forward of Certara, Inc. – NASDAQ:CERT

This article displays the "Enterprise value to EBITDA forward" for Certara, Inc. (NASDAQ: CERT) on TradingView. It provides financial data for the company within the Technology Services sector. The page highlights market information, with various disclaimers regarding data provid

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 00:11
Source
TradingView
The National Law Review Direct company coverage

Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Certara, Inc. (NASDAQ:CERT) following a significant drop in its stock price. This comes after Certara reported a decline in services revenue and bookings for Q1 2026, alongside an exit from its regulatory busin

Tone
Negative 30/100
Event
Regulatory and legal
Published
28 Jun 2026 14:09
Source
The National Law Review
TradingView Direct company coverage

Enterprise value to EBIT forward of Certara, Inc. – NASDAQ:CERT

This article provides financial data for Certara, Inc. (NASDAQ: CERT), specifically focusing on its enterprise value to EBIT forward metric. It also lists general information about the company on TradingView, including market data, news, and community features.

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 12:10
Source
TradingView
TradingView Direct company coverage

Price to book forward of Certara, Inc. – NASDAQ:CERT

The article displays the "Price to book forward" metric for Certara, Inc. (NASDAQ: CERT). It appears to be a financial data point provided by TradingView, with data sourced from ICE Data Services and FactSet Research Systems Inc.

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 06:41
Source
TradingView
TradingView Direct company coverage

Certara, Inc. Actuals & Estimates (NASDAQ:CERT)

This article provides an overview of Certara, Inc. (NASDAQ:CERT) stock, including current price, historical performance, analyst forecasts, and financial data. It details information such as market capitalization, earnings reports, revenue, net income, and volatility, while also

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 14:41
Source
TradingView